Delivery Order SPE2DB22D2108-SPE2DB25FU5FL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,055.90 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 21, 2025, just three days after the award date of July 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a contract value of $24,494.88 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $2,245.93 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 MCG inhalers (12-gram units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 mcg in 12-gram units, valued at $1,789.77. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a child...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This competitive, firm fixed-price delivery order, valued at $1,079.68, was executed on July 25, 2025, with completion targeted for July 28, 2025. The contract does not carry a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency (DLA) awarded a $7,161.41 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 MCG in 12GM units, with an ultimate completion date of July 22, 2025. This is a firm fixed price, non-set-aside contract issued on July 21, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,535.86 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 220 MCG inhalers (12 grams). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.16 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16GM units. This firm fixed-price, competitively awarded delivery order was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the company's Conshohocken, Pennsylvania location. The award carries no set-aside designation, reflecting AmerisourceBergen's ability to compete successfully in open...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,892.80 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 mcg inhalers on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,073.79 for Fluticasone Propionate 50 MCG Spray in 16GM units, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's corporate office location in...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5FLDelivery Order
The Defense Logistics Agency awarded a $6,621.75 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram units, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child action under AmerisourceBergen's larger pharmaceutical supply framework with DLA. This award falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026 that enables global pharmaceutical support for military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor supplying a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for this respiratory medication reflects the company's ongoing role in supporting military medical supply chains through competitively awarded, flexible contract vehicles designed to meet federal healthcare procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 7/25/25 |